JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Silicon Motion
SIMO
$9.33B
| $13.3M | ﹤0.01% |
164,275
+91,619
| +126% | +$7.16M |
2015 Q1
37 quarters
|
|
|
SEM
2152
DELISTED
Select Medical
SEM
| $13.3M | ﹤0.01% |
704,155
-14,850
| -2% | -$253K |
2015 Q2
36 quarters
|
|
|
CHCT
2153
Community Healthcare Trust
CHCT
$404M
| $13.3M | ﹤0.01% |
568,305
+70,672
| +14% | +$1.72M |
2016 Q1
33 quarters
|
|
2154
First Trust Preferred Securities and Income ETF
FPE
$6.04B
| $13.3M | ﹤0.01% |
764,966
-204,370
| -21% | -$3.53M |
2013 Q2
44 quarters
|
|
2155
iShares Russell Top 200 Value ETF
IWX
$3.81B
| $13.2M | ﹤0.01% |
176,694
-21,189
| -11% | -$1.59M |
2021 Q1
13 quarters
|
|
2156
Oceaneering
OII
$4.42B
| $13.2M | ﹤0.01% |
558,029
+147,287
| +36% | +$3.4M |
2013 Q2
44 quarters
|
|
2157
Fidelity MSCI Health Care Index ETF
FHLC
$3.39B
| $13.2M | ﹤0.01% |
192,042
-25,632
| -12% | -$1.73M |
2017 Q3
27 quarters
|
|
2158
Orion
OEC
$319M
| $13.1M | ﹤0.01% |
598,880
-106,215
| -15% | -$2.56M |
2016 Q1
33 quarters
|
|
2159
PUT
Ross Stores
ROST
$74.8B
| $13.1M | ﹤0.01% |
+90,400
| New | +$12.5M |
2024 Q2
0 quarters
|
|
2160
Cogent Communications
CCOI
$422M
| $13.1M | ﹤0.01% |
232,378
-72,286
| -24% | -$4.31M |
2015 Q1
37 quarters
|
|
2161
CALL
Wynn Resorts
WYNN
$7.96B
| $13.1M | ﹤0.01% |
146,400
+10,000
| +7% | +$960K |
2023 Q4
2 quarters
|
|
2162
Amalgamated Financial
AMAL
$1.43B
| $13.1M | ﹤0.01% |
478,165
+56,998
| +14% | +$1.39M |
2018 Q3
23 quarters
|
|
2163
Neuberger Option Strategy ETF
NBOS
$569M
| $13.1M | ﹤0.01% |
+497,385
| New | +$12.9M |
2024 Q2
0 quarters
|
|
2164
iShares Latin America 40 ETF
ILF
$3.8B
| $13.1M | ﹤0.01% |
528,400
-37,521
| -7% | -$1.01M |
2013 Q2
44 quarters
|
|
2165
First Trust Smith Unconstrained Bond ETF
UCON
$3.19B
| $13.1M | ﹤0.01% |
534,908
+184,597
| +53% | +$4.51M |
2023 Q3
3 quarters
|
|
2166
FNB Corp
FNB
$6.14B
| $13.1M | ﹤0.01% |
955,037
-146,604
| -13% | -$1.98M |
2013 Q2
44 quarters
|
|
2167
Protagonist Therapeutics
PTGX
$9.01B
| $13M | ﹤0.01% |
376,588
+139,148
| +59% | +$4.08M |
2017 Q4
26 quarters
|
|
2168
MaxLinear
MXL
$8.35B
| $13M | ﹤0.01% |
647,132
-101,019
| -14% | -$1.99M |
2016 Q2
32 quarters
|
|
|
SAGE
2169
DELISTED
Sage Therapeutics
SAGE
| $13M | ﹤0.01% |
1,199,975
+45,259
| +4% | +$580K |
2014 Q3
39 quarters
|
|
2170
Invesco S&P 500 Quality ETF
SPHQ
$18.8B
| $13M | ﹤0.01% |
205,037
-8,933
| -4% | -$545K |
2022 Q1
9 quarters
|
|
2171
Vista Energy
VIST
$7.15B
| $13M | ﹤0.01% |
285,885
-165,571
| -37% | -$7.32M |
2023 Q2
4 quarters
|
|
2172
Haemonetics
HAE
$4.75B
| $13M | ﹤0.01% |
156,819
-36,746
| -19% | -$3.23M |
2015 Q4
34 quarters
|
|
2173
Yelp
YELP
$983M
| $13M | ﹤0.01% |
350,814
-11,846
| -3% | -$454K |
2013 Q2
44 quarters
|
|
2174
Syndax Pharmaceuticals
SNDX
$1.63B
| $12.9M | ﹤0.01% |
629,880
-52,584
| -8% | -$1.1M |
2016 Q4
30 quarters
|
|
2175
Harley-Davidson
HOG
$2.58B
| $12.9M | ﹤0.01% |
384,953
+68,410
| +22% | +$2.49M |
2013 Q2
44 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.